Please provide your email address to receive an email when new articles are posted on . Compared with methotrexate, systemic therapies for psoriasis either reduced or slightly increased cardiovascular ...
The National Psoriasis Foundation issued a new position statement that clarifies the definition of psoriasis disease severity ...
Patients with psoriasis often have comorbidities that are linked to the systemic inflammation of psoriasis and its treatment, according to study findings published in The Journal of Dermatology. The ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In patients with plaque psoriasis, studies have shown that ...
Older adults with severe or refractory psoriatic disease face a unique challenge: Balancing the need for effective systemic treatment with the increased risk for serious infections. A cohort study ...
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the first patient has been dosed in a global Phase 2 clinical trial (NCT06380907) ...
Incorporating patient-reported outcome measures, such as quality of life, as well as looking into real-world data, is ...
The retrospective analysis, published in the Journal of Clinical Medicine, supports the use of tildrakizumab, an interleukin-23 (IL-23) inhibitor that was FDA approved in 2018 for moderate-to-severe ...
New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity ...
Like other inflammatory conditions, psoriasis often comes with concurrent systemic comorbidities, and physicians should be aware of symptoms that suggest associated conditions. Comorbidities include ...
Topical treatments, such as ointments, creams, lotions, and sprays, are often the first-line treatment for people with psoriasis. As psoriasis progresses or becomes more severe, though, topical ...